Although this might suggest that the leptin signaling pathway is needed for CYP2E1 induction in obesity and NAFLD, hepatic CYP2E1 activity is enhanced in leptin receptor-deficient db/db mice, especially in females [49]. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.